Please upgrade your browser.
The company's lead product candidate is currently in last-stage development as a renal cell cancer treatment.
John Baron MP recently met with nurses, clinicians and patient representatives at an event in the House of Lords on 'Improving Outcomes for Kidney Cancer Patients'.
Doctors will today unveil the world's first sticking plaster that can cure cancer.
By observing a laparoscopic radiofrequency ablation procedure live, and seeing first hand the benefits to patients, Sarasota Memorial Urologist Robert Carey, MD, hopes more surgeons will embrace less invasive cancer treatments.
China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.
Hypoxia-inducible factor (HIF) plays an important role in renal tumourigenesis. In the majority of clear cell RCC (ccRCC), the most frequent and highly vascularized RCC subtype, HIF is constitutively activated by inactivation of the von Hippel-Lindau gene.
According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study is the largest case-control study of kidney cancer to investigate the association with occupational sunlight exposure.
Abstracts: Renal Cell Cancer. Complete information is available on this website: http://www.gucasymposium.org.
As the use of robotics in urology expands beyond the prostate gland, short-term results on robotic partial nephrectomy for stage T1 renal masses show promising oncologic and intraoperative outcomes.
|Powered by NeonCRM|